BACKGROUND/OBJECTIVES: Beneficial effects of vitamin E on insulin sensitivity have been reported in observational and shortterm intervention studies in non-pregnant populations. We aimed to investigate whether dietary vitamin E intake during the second trimester would be associated with glucose metabolism later in pregnancy and whether this association would be influenced by an insulin-sensitizing hormone adiponectin. SUBJECTS/METHODS: Women with singleton pregnancies (n ¼ 205) underwent a 3-h oral glucose tolerance test at 30 weeks gestation and were asked to recall second trimester dietary intake. RESULTS: Higher dietary vitamin E intake was associated with lower fasting glucose, lower HOMA insulin resistance, and higher Matsuda insulin sensitivity index after covariate adjustment including serum adiponectin among women consuming daily multivitamin supplements (all Pp0.03). CONCLUSIONS: Lower dietary vitamin E intake during the second trimester is associated with hyperglycemia and insulin resistance later in pregnancy among women consuming daily multivitamin supplementations. Further, these associations are not influenced by adiponectin. Keywords: vitamin E; insulin resistance; insulin sensitivity; hyperglycemia; pregnancy INTRODUCTION Pregnant women experience rapid metabolic changes in late pregnancy to support the growing fetus and prepare for delivery.
INTRODUCTION
Pregnant women experience rapid metabolic changes in late pregnancy to support the growing fetus and prepare for delivery. 1 Most women are able to compensate for deterioration in insulin sensitivity in late pregnancy, but some experience gestational hyperglycemia and insulin resistance. 1 Vitamin E, which has structural similarities to the insulin-sensitizing drug thiazolidinediones (TZDs), 2 has been associated with improved metabolic status in non-pregnant adults. [3] [4] [5] In a randomized trial, short-term vitamin E supplementation resulted in improved glucose metabolism among diabetes-free adults. 6 This shortterm effect may be beneficial among young pregnant women experiencing rapid metabolic changes during a relatively brief period, 1 but metabolic effects of vitamin E have not been explored extensively in the context of pregnancy. 7 We hypothesized that dietary vitamin E intake during the second trimester would be associated with glucose metabolism later in pregnancy and that the association would be influenced by adiponectin. Recent evidence from animal models suggest that vitamin E may induce the expression of adiponectin, an insulin-sensitizing hormone. 2 
SUBJECTS AND METHODS
In 2009-2010, pregnant women were recruited in Toronto as previously described. 8 The study was approved by the Mount Sinai Hospital Research Ethics Board. Women with singleton pregnancies (n ¼ 205) underwent a 3-h 100 g oral glucose tolerance test at 30 (interquartile range: 29, 32) weeks gestation. 8 Biochemical analyses were conducted as previously described. 9 Gestational diabetes (GDM) was defined using the National Diabetes Data Group criteria. Matsuda insulin sensitivity index (ISogtt) and homeostasis model assessment of insulin resistance (HOMA-IR) were assessed. 9 The modified Block food frequency questionnaire was used as previously described. 8, 9 Women were asked about the frequency and amount of each food and beverage item consumed during the second trimester of pregnancy in addition to the frequency of multiple and single vitamin supplements consumed. Anthropometric assessments were performed, and questionnaires were administered to obtain sociodemographic, medical and lifestyle information. 8, 9 General linear models were used to assess the associations of dietary vitamin E intake with continuous fasting glucose, HOMA-IR, log ISogtt and adiponectin with adjustment for covariates, potential confounders of glucose and vitamin E metabolism. Subgroup analysis was performed among those who consumed multivitamin supplement as recommended during pregnancy (that is, daily). Participants using single vitamin E supplements (that is, those consuming exceptionally high doses of vitamin E) were also excluded from this sub-analysis. Two-sided Po0.05 was considered to be statistically significant using SAS software, version 9.3 (SAS Institute, Cary, NC, USA).
RESULTS
Characteristics of participants are presented in Table 1 was associated with lower fasting glucose, HOMA-IR and higher ISogtt later in pregnancy (Table 2 ; model 1; all Pp0.03). These associations remained significant after additional adjustment for medical history and lifestyle variables (model 2; both Pp0.02), except for the association with ISogtt which was attenuated (P ¼ 0.06). Dietary vitamin E intake was not associated with adiponectin (Table 2) .
Among participants who consumed vitamin E supplements from multivitamin as recommended (that is, daily) (n ¼ 167), higher dietary vitamin E intake during the second trimester was associated with lower fasting glucose, HOMA-IR and higher ISogtt (Table 2; 
DISCUSSION
Our findings suggest that lower dietary vitamin E intake during the second trimester of pregnancy is associated with hyperglycemia and insulin resistance later in pregnancy independent of adiponectin, among women consuming multivitamin supplementations as recommended. These data are consistent with a previous randomized trial where 4 months of vitamin E supplementation reduced area under the curve for glucose and increased total glucose disposal in diabetes-free participants. 6 These two studies suggest that vitamin E may influence shortterm glucose metabolism in healthy individual. This could be particularly valuable in pregnancy when rapid metabolic changes occur over a relatively brief period to support fetal growth.
As vitamin E has a similar molecular structure to that of the TZD drugs that are known to function through PPARg-mediated upregulation of adiponectin, 2 we hypothesized that the associations of dietary vitamin E intake with hyperglycemia General linear model analyses were used with adjustment for age, ethnicity (white/non-white), and daily intake of energy in model 1.
b Model 2 was additionally adjusted for pregravid BMI, family history of type 2 diabetes (yes/no), % total fat of daily energy intake, gestational weeks at the time of the OGTT, gestational weight gain up to the OGTT, vitamin E supplement (yes/no; excluded in sub-analysis among daily multivitamin users) and adiponectin (excluded when testing adiponectin as a dependent variable).
and insulinemia would be influenced by serum adiponectin concentrations in pregnant women. However, the associations of lower vitamin E intake with hyperglycemia and insulinemia were independent of adiponectin, and no interaction was observed between vitamin E intake and adiponectin in our study. Using adiponectin knock-out ob/ob mice, TZD induced amelioration of insulin resistance and diabetes was demonstrated adiponectin-dependently in the liver and adiponectinindependently in skeletal muscle. 10 Our data suggest then that vitamin E intake from food, in addition to supplements, may have assisted in establishing a favorable metabolic status through increased glucose uptake in skeletal muscle during pregnancy involving the mechanisms alternative to the adiponectin pathways.
The magnitude of reported associations must be interpreted with caution because we had a high proportion of women with a family history of type 2 diabetes and abnormal glucose challenge test. Further, we did not have detailed information on sources of vitamin supplements although we had the frequency of supplement use. To address this limitation, we conducted a sub-analysis among women consuming the recommended daily multivitamin supplement intake only. Our null finding on GDM was likely because we were underpowered to assess dichotomous outcomes. Also, the reported associations might have been influenced by unaccounted confounding including other lifestyle factors and hemodilution (that is, increased maternal blood volume during pregnancy might have obscured relationships with biomarkers).
Despite these limitations, our findings support the need for further investigations to understand the underlying mechanisms involved in vitamin E metabolism and optimal requirement of vitamin E during pregnancy.
